GRXCR2
Glutaredoxin domain-containing cysteine-rich protein 2
Also known as: DFNB101, GRCR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NFK2
- Gene
- GRXCR2
- Ensembl
- ENSG00000204928
- Chromosome
- 5
- Canonical length
- 248 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein containing a glutaredoxin domain, which functions in protein S-glutathionylation. A mutation in this gene was found in a family with autoosomal recessive nonsyndromic sensorineural deafness-101. [provided by RefSeq, Jun 2014]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>A6NFK2|GRXCR2
1 MEDPEKKLNQ KSDGKPRKVR FKISSSYSGR VLKQVFEDGQ ELESPKEEYP HSFLQESLET
61 MDGVYGSGEV PRPQMCSPKL TAQRISVFRE GNAYTLAGGQ PRFNDYKAND HKPLPIIDFG
121 KIIIYTNNLK IIRTPMDKRD FVRKILQKEE EAEEESLMNK EESYGGRDQH DRPLVEAEST
181 LPQNRYTQEG DIPEDSCFHC RGSGSATCSL CHGSKFSMLA NRFKESYRAL RCPACNENGL
241 QPCQICNQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRXCR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 0.9 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 0.9 nTPM
- testis: 0.8 nTPM
- thymus: 0.5 nTPM
- skin: 0.4 nTPM
- epididymis: 0.3 nTPM
- salivary gland: 0.3 nTPM
Single-cell type
- cardiomyocytes: 151 nCPM
- late spermatids: 35 nCPM
- early spermatids: 30 nCPM
- epicardial cells: 16 nCPM
- thymic myoid cells: 6.8 nCPM
- lacrimal acinar cells: 5.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.4 nTPM
- basal ganglia: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
- midbrain: 0.1 nTPM
- pons: 0.1 nTPM
- white matter: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRXCR2.
Disease | AllUniProt
Conditions GRXCR2 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 101 (DFNB101) MIM:615837
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 106 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 101
- Hearing loss, autosomal recessive
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.57
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.85
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Heat shock protein DnaJ, cysteine-rich domain superfamily
- GRXCR1/2, C-terminal domain
- Glutaredoxin domain-containing cysteine-rich protein 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRXCR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRXCR2 as an antibody target. Whether an autoantibody or antibody against GRXCR2 could matter depends on whether native GRXCR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRXCR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRXCR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...